Robert D. Simari

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients”.

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients

JACC CardioOncology(2020)10.1016/j.jaccao.2020.09.001

N/A

0DataRank · unranked

50 citations

Emerson C. Perin, James T. Willerson, Phillip C. Yang, Jay H. Traverse, Timothy D. Henry +29 more

Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials

PLoS ONE(2020)10.1371/journal.pone.0237401

N/A

0DataRank · unranked

6 citations

Lourdes Chacon‐Alberty, Ronak Derakhshandeh, Hilda J. Rodriguez, Daniel D Han, Dmitry Kostyushev +7 more

A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

European Journal of Heart Failure(2021)10.1002/ejhf.2178

N/A

0DataRank · unranked

166 citations

Raul D. Mitrani, Joshua M. Hare, Carl J. Pepine, Emerson C. Perin, James T. Willerson +33 more